11
Feb
Dr Taime Sylvester Africa is one of the richest biorepositories on Earth, holding extraordinary microbial diversity, vast traditional medicinal knowledge, and populations that have, for centuries, contributed biological samples, genomic data, and indigenous expertise to the global health enterprise. Yet when vaccines are developed, drugs reach the market, and patents are filed, Africa is rarely at the table where the rewards are divided. From the negotiating floors of the World Health Organisation (WHO) to the benchtops of laboratories at universities, the same pattern repeats: African biological resources flow outward, and the benefits – whether they be intellectual, economic or strategic…
